Last reviewed · How we verify
AZD4205 and itraconazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
AZD4205 and itraconazole (AZD4205 and itraconazole) — Dizal Pharmaceuticals.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| AZD4205 and itraconazole TARGET | AZD4205 and itraconazole | Dizal Pharmaceuticals | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- AZD4205 and itraconazole CI watch — RSS
- AZD4205 and itraconazole CI watch — Atom
- AZD4205 and itraconazole CI watch — JSON
- AZD4205 and itraconazole alone — RSS
Cite this brief
Drug Landscape (2026). AZD4205 and itraconazole — Competitive Intelligence Brief. https://druglandscape.com/ci/azd4205-and-itraconazole. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab